Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials-Reference-Cited by-同舟云学术

Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials

Published:2004 Issue:3 Volume:39 Page:592-598
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Caldwell Stephen H.,Chang Charissa,Macik B. Gail

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.20123/fullpdf

Reference57 articles.

1. Variation between centers in technique and guidelines for liver biopsy

2. The use of blood components prior to invasive procedures: a critical appraisal. In: editor. Transfusion Therapy: Clinical Principles and Practice. Bethesda, MD: AABB Press, 1999: 153-156.

3. Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000

4. The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment;WORLD J CLIN CASES;2021

2. Establishment of a risk assessment score for deep vein thrombosis after artificial liver support system treatment;World Journal of Clinical Cases;2021-11-06

3. Pediatric Hepatic Physiology;Pediatric Surgery;2020

4. Effect of a Rapidly Degrading Presolidified 10 kDa Chitosan/Blood Implant and Subchondral Marrow Stimulation Surgical Approach on Cartilage Resurfacing in a Sheep Model;CARTILAGE;2016-11-11

5. Intracranial Pressure Monitoring in Acute Liver Failure: Institutional Case Series;Neurocritical Care;2016-03-10